Viewing nowLanfuton Capsule 15 mg ( lansoprazole )
Lansoprazole 15mg
Hard capsule · Prescription medication
Samchundang Pharm Co., Ltd.

MFDS item code 201402846 · Approved 2014.06.26 · Insurance code 651204130
Treatment and prevention of ulcers and eradication of Helicobacter pylori; treatment of reflux disease; suppression of gastric acid hypersecretion
This medication is used for the short-term treatment of active duodenal ulcers and active benign gastric ulcers. It also helps eradicate Helicobacter pylori to prevent the recurrence of duodenal ulcers and is used in maintenance therapy after treatment. It is effective in treating gastric ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs) and in reducing the risk of occurrence. It is used for short-term treatment of gastroesophageal reflux disease and erosive reflux esophagitis, as well as maintenance therapy following treatment. Finally, it is useful in treating pathological hypersecretion conditions such as Zollinger-Ellison syndrome. Overall, it is used to improve various ulcerative and inflammatory conditions related to gastrointestinal disorders.
This medication should be administered before meals. For patients who have difficulty swallowing the medication, open the capsule, mix its contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. Do not chew or crush the contents after opening this medication before taking it. ○ Adults 1. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. 2. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. 3. Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days, if needed. 2) Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. 4. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The duration of the comparative clinical trials did not exceed 12 months. 5. Treatment of NSAID-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The duration of the comparative clinical trials did not exceed 8 weeks. 6. Reduction of the risk of NSAID-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The duration of the comparative clinical trials did not exceed 12 weeks. 7. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks 8. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. 9. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. 10. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dosage of lansoprazole for pathological hypersecretory conditions varies from patient to patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued as long as it is clinically effective. Doses of 90 mg per dose up to twice daily have been administered. When the total daily dose exceeds 120 mg, it should be divided. ○ Elderly patients Because clearance of this medication is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. ○ Patients with hepatic impairment Use with caution, including dose adjustment, because metabolism and excretion of this medication may be delayed in patients with hepatic impairment.
○ Children and adolescents aged 12 ∼ 17 years Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks ○ Children aged 1 ∼ 11 years Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, 30 kg or less: 15 mg once daily for 12 weeks Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, over 30 kg: 30 mg once daily for 12 weeks
This medication should not be used by patients who have previously had an allergic reaction to certain components or benzimidazoles as they may experience severe allergic reactions or difficulty in breathing. Patients with an allergy to penicillin-type antibiotics or macrolide antibiotics should not use this medication concurrently. Special caution is necessary when using it for Helicobacter pylori eradication therapy. Pregnant women should avoid this medication as it may pose a risk to the fetus. Nursing mothers should consult a doctor before taking this medication and may need to discontinue breastfeeding. Patients with impaired liver or kidney function, the elderly, children, and those with a history of drug allergies should exercise particular caution when using this medication. This medication can rarely cause severe allergic reactions, blood abnormalities, liver dysfunction, or skin diseases, so if any abnormal symptoms occur, use should be discontinued immediately and medical attention sought. Additionally, long-term use may cause vitamin B12 deficiency or hypomagnesemia, requiring regular testing. Because this medication suppresses gastric acid secretion, there may be interactions with other medications. It is particularly necessary to consult with a doctor or pharmacist when co-administering with HIV medications, antibiotics, anticoagulants, etc. During the use of this medication, dizziness, drowsiness, or visual disturbances may occur, so caution is advised when driving or operating machinery. There are no specific antidotes for overdose; management may include gastric lavage or symptomatic treatment depending on symptoms. Store out of reach of children and do not transfer to other containers for safety. Long-term use of this medication may mask symptoms of malignant tumors; therefore, if symptoms such as weight loss, hematemesis, or melena occur, consult a doctor immediately.
Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial swelling, shortness of breath, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membranous colitis, bloody stool, abdominal pain, diarrhea, headache, abdominal enlargement, allergic reaction, back pain, weakness, candidiasis, malignancy, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal bowel movements, enteritis, gastritis, gastrointestinal abnormalities, gastrointestinal diseases, gastrointestinal bleeding, loss of appetite, bezoar, pyloric spasm, cholelithiasis, constipation, xerostomia, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, fecal discoloration, distension, gastric nodules, gastric fundic polyps, gastroenteritis, upper gastrointestinal bleeding, hematemesis, increased appetite, increased salivation, anal bleeding, stomatitis, tongue disorders, glossitis, gingival bleeding, post-prandial hypersensitivity, colitis, vomiting, nausea, gastric candidiasis, rectal disorders, bleeding, diabetes, goiter, hypothyroidism, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disorders, joint disorders, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia, ptosis, synovitis, anxiety, amnesia, restlessness, confusion, depression, dizziness, syncope, hallucinations, hemiparesis, worsening hostility, decreased libido, increased libido, neurosis, sensory disturbances, abnormal thoughts, convulsions, dementia, depersonalization, diplopia, hyperkinesia, hypertonia, sensory loss syndrome, insomnia, sleep disorders, drowsiness, tremors, acne, hair loss, pruritus, rash, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweat, abnormal vision, amblyopia, blepharitis, cataracts, conjunctivitis, dry eyes, ear diseases, eye diseases, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, eye pain, otitis media, taste disturbance, tinnitus, constricted vision, urinary disorders, renal pain, penile disorders, testicular disorders, urethral pain, polyuria, frequent urination, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, hepatotoxicity, pancreatitis, taste abnormalities, aplastic anemia, leukopenia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fractures, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorders, urinary incontinence, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, increased total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, abdominal pain, diarrhea, abdominal bloating, stomatitis, heartburn, gastroesophageal reflux, shortness of breath, vomiting symptoms, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time and ensure safe use.
A white to light brown granular substance held within a white opaque hard capsule.
For domestic use - 30 capsules/bottle, For domestic use - 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLansoprazole 15mg
Hard capsule · Prescription medication
Samchundang Pharm Co., Ltd.

Lansoprazole 15mg
Hard capsule · Prescription medication
Korea Pharmaceutical Co., Ltd.

Lansoprazole 15mg
Orally disintegrating Tablet · Prescription medication
Takeda Pharmaceuticals Korea Co., Ltd.

Lansoprazole 30mg
Orally disintegrating Tablet · Prescription medication
Takeda Pharmaceuticals Korea Co., Ltd.
Lansoprazole 15mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Lansoprazole 30mg
Hard capsule · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
Lansoprazole 30mg
Hard capsule · Prescription medication
Aprogen Biologics Co., Ltd.

Lansoprazole 30mg
Hard capsule · Prescription medication
Samchundang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.